Jacques Maas: Transformative Strategies for Endometriosis and Adenomyosis
Jacques Maas, Head Center for Reproductive Medicine at Maastricht UMC+, shared a post on LinkedIn:
“When two research schools of Maastricht University Faculty of Health, Medicine and Life Sciences and Maastricht UMC+: MERLN Institute for Technology-Inspired Regenerative Medicine and GROW – Research Institute for Oncology and Reproduction find each other and utilize long-standing, fruitful collaborations in the Netherlands in the field of endometriosis and adenomyosis, the impossible apparently becomes possible.
Roman Truckenmüller, Paul Wieringa, Niloofar Tahmasebi, and Erik Vrij have been awarded the prestigious NWO (Dutch Research Council) Perspective Grant for the project ‘FEMCHIP – Tackling endometriosis and adenomyosis through improved clinical diagnostics and human in vitro models to unlock understanding and therapy development’.
FEMCHIP aims to transform the diagnosis and treatment of endometriosis and adenomyosis by developing innovative imaging tools, creating advanced 3D disease models, and identifying new therapies to reduce pain and improve fertility.
The FEMCHIP consortium is a collaboration between Maastricht University, MUMC+, UMC Utrecht, Amsterdam UMC, and Radboud University. To address the urgent need for better diagnostics and treatments, FEMCHIP collaborates closely with Dutch and international industry partners, patient organizations, and innovation hubs to accelerate solutions for these underserved diseases.
Programme lead: prof. dr. Roman K. Truckenmüller
Co-applicants: dr. ir. P.A.W. Wieringa, dr. ir. E.J. Vrij, dr. Z.N. Tahmasebi Birgani, Jacques Maas, Salwan Al-Nasiry, Andrea Romano, Velja Mijatovic, Judith Huirne, Arjan W. Griffioen, Lynda Juffermans, Bernadette de Bakker, Lennie Van Hanegem, Willem Verpoest, Gaby Steba, Klaas Mulder, prof. dr. M. Vermeulen
Consortium: Endometriose Stichting, Genomics, 300MICRONS GmbH, chiron, CimCure B.V., Fluidnatek and Spinbox by Bioinicia, ibidi GmbH, Little Miracles Foundation, Merck Group, Metatissue, Olink, Optics11 Life, Proefdiervrij, ReGEN Biomedical, Samsung Healthcare, STEMCELL Technologies, Theramex, TNO, and Topigs Norsvin”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Apr 15, 2026, 11:37Ally Murji: Honoured to be Part of the Canadian Session at the SEUD Meeting
-
Apr 15, 2026, 11:00Scammers are Targeting ESHRE2026 Attendees With Fake Registration and Hotel Offers – ESHRE
-
Apr 15, 2026, 10:24Join Us This Friday for Our “Research in Progress” – SRF
-
Apr 15, 2026, 10:20The Importance of Fertility Preservation in Turner Syndrome – RBMO
-
Apr 15, 2026, 10:16Marlena Fejzo: Our Study Identifying 6 New Genes Associated with Hyperemesis Gravidarum
-
Apr 15, 2026, 10:07Applications Are Open for the 2027 Cohort of the ASRM/SRBT CELL Program – ASRM
-
Apr 14, 2026, 15:14This Month’s F and S On Air Podcast Is Out Now – Fertility and Sterility
-
Apr 14, 2026, 14:51Lydia Akpan: Key Signs of Oocyte Dysmorphism
-
Apr 14, 2026, 14:42Emre Göksan Pabuçcu: Honored to Speak at the 12th National Gynecological Endoscopy Congress